![Meriam Kabbaj](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meriam Kabbaj
Director Técnico/Científico/I+D en GENFIT .
Perfil
Meriam Kabbaj has founded Versantis AG in 2015, where she holds the title of Chief Operating Officer & Director.
She is currently the Chief Technology Officer at Genfit SA since 2022.
Dr. Kabbaj has a doctorate degree from the University of Montréal.
Cargos activos de Meriam Kabbaj
Empresas | Cargo | Inicio |
---|---|---|
GENFIT | Director Técnico/Científico/I+D | 01/12/2022 |
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Fundador | 01/01/2015 |
Formación de Meriam Kabbaj.
University of Montréal | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GENFIT | Health Technology |
Empresas privadas | 1 |
---|---|
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Meriam Kabbaj